Table 1. The identified compounds were tested for their growth inhibition rate (%) for the MG-63 cancer cells at 10 μM by an MTT assay.
Compounds ID | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 5 | Cisplatin b |
Inhibition rate (%) | NI a | 68.9 ± 7.8 | 48.7 ± 5.9 | 50.2 ± 3.1 | 88.7 ± 8.9 | NH | 67.8 ± 8.9 | NI | 79.5 ± 4.3 |
aNI: No inhibition.
bCisplatin was used as positive control, and the EC50 is 5.42 μM, which was in line with the reference data.17